Stock Ratings / Health Care / BIO / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Bio-Rad Laboratories Inc. (BIO) 12-Month Stock Forecast & Price Target Cone

$384.40 -0.19% NYSE • Public Delayed / 60s Snapshot

Bio-Rad Laboratories Inc. (BIO) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (59/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+124.3% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D+ • SELL / AVOID Cap $10.28B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+0.5% Base Target

WHALE OPTIONS TUG-OF-WAR:52% Call Buyers ($2.3M)

48% PutsMax Pain: $377.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your BIO Position Size: $10,000

Shares at $384.40: 26.0 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $301.18

$7,835

$-2,165 (-21.6%)

12M Consensus BaseTarget $386.13

$10,045

+$45 (+0.5%)

12M Bull Case BreakoutTarget $455.63

$11,853

+$1,853 (+18.5%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$402	74%	A
Goldman SachsSector Coverage Lead	BUY	$428	69%	B
JP MorganUS Large-Cap Research	HOLD	$344	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring BIO)

✓Live walkthrough of BIO's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

BIO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +32.86%▲ ASCENDING CHANNEL

2026-10-30O $381.1H $384.0L $368.5C $372.2VOL 183.1K

RES: $450.8SUP: $353.8SMA50: $374.8SMA200: $313.4

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BIO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BIO Butterfly Map → + Track BIO →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

5.0%/yr Implied 5Y Growth

vs. +0.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BIO today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BIO. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BIO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

BIO Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is BIO's 12-month stock price target?

Bio-Rad Laboratories Inc. (BIO) carries a 12-month consensus base price target of $386.13 (+0.5% from $384.40), with a bull-case target of $455.63 and a bear-case floor of $301.18.

Is BIO stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates BIO D+ (Sell — SELL) with an RQD Confidence score of 59/100.

Direct Sub-Reports: BIO RQD Cockpit BIO 12M Forecast BIO Earnings & Move BIO Dividends & DRIP BIO Insiders & 13F BIO Whale Options BIO Profit Sankey BIO News & Why